Andrew Jess Dannenberg, M.D.

• Research
• Biography
• Publications
• Global Health

Publications

Journal articles:

1. Feldberg RS, Lucas JL and Dannenberg A. 1982. A damage-specific DNA binding protein. Large scale purification from human placenta and characterization. J. Biol. Chem. 257 (11):6394-401.
2. Dannenberg A and Zakim D. 1988. Effects of prochlorperazine on the function of integral membrane proteins. Biochem. Pharmacol. 37:1259-1262.
3. Dannenberg A, Rotenberg M and Zakim D. 1989. Regulation of UDP-glucuronosyltransferase by lipid-protein interactions. Comparison of the thermotropic properties of pure, reconstituted enzyme with microsomal enzyme. J. Biol. Chem, 264 (1):238-242.
4. Dannenberg A, Godwin T, Rayburn J, Goldin H and Leonard M. 1989. Multifocal adenocarcinoma of the proximal small intestine in a patient with nontropical sprue. J. Clin. Gastro, 11(1):73-76.   
5. Harris L, DeCosse J and Dannenberg A. 1989. Abdominal actinomycosis: Evaluation by computed tomography. Am. J. Gastroenterol., 84(2):198-200.
6. Zakim D and Dannenberg A. 1990. Thermal instability of microsomal glucose-6-phosphatase. J. Biol. Chem., 265 (1):201-208.
7. Dannenberg A, Wong T and Zakim D. 1990. Effect of brief treatment at alkaline pH on the properties of UDP-glucuronosyltransferase. Arch. Biochem. Biophys., 277(2):312-317.
8. Dannenberg A, Kavecansky J, Scarlata S and Zakim D. 1990. Organization of microsomal UDP-glucuronosyltransferase. Activation by treatment at high pressure. Biochemistry, 29(25):5961-5967.
9. Fine S, Gaynor M, Isom O and Dannenberg A. 1990. Carcinoid tumor metastatic to the heart. Am. J. Med., 89:690-692.
10. Dannenberg A, Wong T, Zakim D and Eibl H. 1990. Synthesis and use of a lysolecithin analogue for the purification of UDP-glucuronosyltransferase. Anal. Biochem., 191(1):183-186.
11. Lambroza A and Dannenberg A. 1991. Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am. J. Gastroenterol., 86:89-91.
12. Kavecansky J, Dannenberg AJ and Zakim D. 1992. Effects of high pressure on the catalytic and regulatory properties of UDP-glucuronosyltransferase in intact microsomes. Biochemistry, 31:162-168.
13. Zakim D and Dannenberg AJ. 1992. How does the microsomal membrane regulate UDP-glucuronosyltransferases? Biochem. Pharmacol., 43:1385-1393.
14. Ergun GA, Lin AN, Dannenberg AJ and Carter DM. 1992. Gastrointestinal manifestations of epidermolysis bullosa: a study of 101 patients. Medicine, 71:121-127.
15. Dannenberg AJ, Worman H and Scarlata S. 1992. Developmental changes in the amount and functional state of UDP-glucuronosyltransferase. Biochim. Biophys. Acta, 1116:250-255.    
16. Dannenberg AJ and Zakim D. 1992. Dietary lipid regulates the amount and functional state of UDP-glucuronosyltransferase in rat liver. J. Nutr., 122:1607-1613.
17. Dannenberg AJ and Yang EK. 1992. Effect of dietary lipids on levels of UDP-glucuronosyltransferase in liver. Biochem. Pharmacol., 44:335-340.   
18. Yang EK, Radominska A, Winder BS and Dannenberg AJ. 1993. Dietary lipids coinduce multiple xenobiotic metabolizing enzymes in rat liver. Biochim. Biophys. Acta, 1168:52-58.
19. Nanji AA, Zhao S, Lamb RG, Sadrzadeh SMH, Dannenberg AJ and Waxman DJ. 1993. Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: relationship to cytochrome P450 2E1 induction and conjugated diene formation. Alcoholism: Clin. Exp. Res., 17:598-603.
20. Dannenberg AJ, Yang EK and Aharon D. 1993. Dietary lipids induce phase 2 enzymes in rat small intestine. Biochim. Biophys. Acta, 1210:8-12.
21. Dannenberg AJ and Reidenberg MM. 1994. Dietary fatty acids are also drugs. Clin. Pharmacol. Ther., 55(1):5-9.
22. Roston AD, Rahmin M, Eng A and Dannenberg AJ. 1994. Strangulated obturator hernia: a rare cause of small bowel obstruction. Am. J. Gastroenterol., 89(2):277-278.
23. Kashfi K, Rimarachin JA, Weksler BB and Dannenberg AJ. 1994. Differential induction of glutathione S-transferase in rat aorta versus liver. Biochem. Pharmacol., 47(10):1903-1907.
24. Nanji AA, Zhao S, Lamb RG, Dannenberg AJ, Sadrzadeh SMH, Khettry U and Waxman DJ. 1994. Changes in cytochromes P450 2E1, 2B1, 4A, phospholipases A and C in the intragastric feeding model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. Alcoholism: Clin. Exp. Res., 18(4):902-908.
25. Nanji AA, Sadrzadeh SMH and Dannenberg AJ. 1994. Liver microsomal fatty acid composition in ethanol-fed rats: Effect of different dietary fats and relationship to liver injury. Alcoholism: Clin. Exp. Res., 18(4):1024-1028.
26. Kashfi K, Yang EK, Roy Chowdhury N, Roy Chowdhury J and Dannenberg AJ. 1994. Regulation of UDP-glucuronosyltransferase expression by phenolic antioxidants. Cancer Res., 54:5856-5859.
27. Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR and Waxman DJ. 1994. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol fed rats. Alcoholism: Clin. Exp. Res., 18(5):1280-1285.   
28. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M and Dannenberg AJ. 1995. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology, 109:547-554.
29. Lambroza A, Tighe MK, DeCosse JJ and Dannenberg AJ. 1995. Disorders of the rectus abdominis muscle and sheath: a 22 year experience. Am. J. Gastroenterol., 90(8):1313-1317.
30. Catania VA, Dannenberg AJ, Luquita MG, Sanchez Pozzi EJ, Tucker JK, Yang EK and Mottino AD. 1995. Gender-related differences in the amount and functional state of rat liver UDP-glucuronosyltransferase. Biochem. Pharmacol., 50(4):509-514, 1995.
31. Kashfi K and Dannenberg AJ. 1995. Omeprazole co-induces multiple xenobiotic metabolizing enzymes in the rat. Ann. N.Y. Acad. Sci., 768:237-242.32.   Yang EK, Kashfi K, Roy Chowdhury J, Roy Chowdhury N and Dannenberg AJ. 1995. Phenolic antioxidants induce UDP-glucuronosyltransferase in rat liver. Ann. N.Y. Acad. Sci., 768:231-236.
32. Kashfi K, McDougall CJ and Dannenberg AJ. 1995. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat versus the human. Clin. Pharmacol. Ther., 58:625-630.
33. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ and Bertagnolli M. 1996. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56:2556-2560.
34. Nanji AA, Yang EK, Fogt F, Sadrzaeh SMH and Dannenberg AJ. 1996. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J. Pharmacol. Exp. Ther., 277:1694-1700.
35. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB and Dannenberg AJ. 1996. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56:4424-4429.
36. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR and Dannenberg AJ. 1997. Enhanced cyclooxygenase-2 gene expression in experimental alcoholic liver disease in the rat. Gastroenterology, 112:943-951.
37. Schuman RW, Rahmin M and Dannenberg AJ. 1997. Scurvy and the gastrointestinal tract. Gastrointest. Endosc., 45:195-196.
38. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H and Dannenberg AJ. 1997. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Res., 57: 1081-1085.
39. Kelley DJ, Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonetti JT and Dannenberg AJ. 1997. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis, 18: 795-799.
40. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H and Dannenberg AJ. 1997. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res., 57: 2890-2895.
41. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR and Dannenberg AJ. 1997. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and TNF-a and reverse fibrosis in experimental alcoholic liver disease, Hepatology, 26:1538-1545.   
42. Subbaramaiah K, Telang N, Bansal MB, Weksler BB and Dannenberg AJ. 1997. Cyclooxygenase-2 gene expression is up-regulated in transformed mammary epithelial cells. Ann. N.Y. Acad. Sci., 833:179-185.
43. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP and Dannenberg AJ. 1997. Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids. Ann. N.Y. Acad. Sci., 833:173-178.
44. Zhang F, Subbaramaiah K, Altorki N and Dannenberg AJ. 1998. Dihydroxy bile acids induce the transcription of cyclooxygenase-2. J. Biol. Chem., 273:2424-2428.
45. Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A and Bertagnolli MM. 1998. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis, 19:87-91.
46. Spingarn A, Sacks PG, Kelley D, Dannenberg AJ and Schantz SP. 1998. Synergistic effects of 13-cis-retinoic acid and arachidonic acid cascade inhibitors on growth of head and neck squamous cell carcinoma in vitro. Otolaryngol Head Neck Surg, 118:159-164.
47. Bass NM, Appel R, Goetzl EJ, Dannenberg AJ and Nanji AA. 1998. Peroxisome proliferator-activated receptor-a-mediated gene expression and adaptation to fatty acid overload in alcoholic liver disease. Alcoholism: Clin. Exp. Res., 22:749-750.
48. Dannenberg AJ and Nanji AA. 1998. Dietary saturated fatty acids: a novel treatment for alcoholic liver injury. Alcoholism: Clin. Exp. Res., 22:750-752.
49. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM and Dannenberg AJ. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273:21875-21882.
50. Subbaramaiah K, Michaluart P, Chung WJ and Dannenberg AJ. 1998. Resveratrol inhibits the expression of cyclooxygenase-2 in human mammary and oral epithelial cells. Pharm. Biol., 36: 35-43.
51. Mahmoud NN, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark H and Bertagnolli MM. 1998. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery, 124:225-231.
52. Subbaramaiah K, Chung WJ and Dannenberg AJ. 1998. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of ERK/JNK and p38 pathways. J. Biol. Chem., 273: 32943-32949.
53. Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K and Sporn MB. 1999. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO), with potent differentiating, anti-proliferative and anti-inflammatory activity. Cancer Res., 59:336-341.
54. Mahmoud NN, Dannenberg AJ, Bilinski RT, Mestre JR, Chadburn A, Churchill M, Martucci C and Bertagnolli MM. 1999. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis, 20:299-303.
55. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT and Fahey TJ. 1999. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59:987-990.
56. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL and Dannenberg AJ. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59:991-994.
57. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K and Dannenberg AJ. 1999. Curcumin inhibits cyclooxygenase-2 transcription in bile acid and phorbol ester-treated human gastrointestinal cells. Carcinogenesis, 20:445-451.
58. Lee F-YJ, Li Y, Yang EK, Yang SQ, Lin HZ, Trush MA, Dannenberg AJ and Diehl AM. 1999. Phenotypic abnormalities in macrophages from leptin-deficient obese mice. Am. J. Physiol. 45:C386-C394.
59. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ and Brown AMC. 1999. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res., 59:1572-1577.
60. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A and Dannenberg AJ. 1999. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem., 274:10911-10915.
61. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Mestre JR, Grunberger D, Sacks PG, Tanabe T and Dannenberg AJ. 1999. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res., 59:2347-2352.
62. Oliveria SA, Christos PJ, Talley NJ and Dannenberg AJ. 1999. Heartburn risk factors, knowledge and prevention strategies. A population-based survey of individuals with heartburn. Arch. Int. Med., 159:1592-1598.
63. Ren Q, Murphy SE, Dannenberg AJ, Park JY, Tephly TR and Lazarus P. 1999. Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1. Drug Metab. Disp., 9:1010-1016.
64. Matsuura H, Sakaue M, Kamitani H, Subbaramaiah K, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J and Jetten AM. 1999. Regulation of cyclooxygenase-2 by interferon-gamma in normal human epidermal keratinocytes. Defective signaling in squamous carcinoma cell lines, J. Biol. Chem., 274:29138-29148.
65. Dannenberg AJ and Zakim D. 1999. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Sem. in Oncol., 26:499-504.   
66. Subbaramaiah K, Michaluart P, Chung WJ, Tanabe T, Telang N and Dannenberg AJ. 1999. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann. N.Y. Acad. Sci., 889:214-223.
67. Mestre JR, Chan G, Zhang F, Yang EK, Sacks PG, Boyle JO, Shah JP, Edelstein D, Subbaramaiah K and Dannenberg AJ. 1999. Inhibition of cyclooxygenase-2 expression: an approach to preventing head and neck cancer. Ann. N.Y. Acad. Sci., 889: 62-71.
68. Yan Z, Subbaramaiah K, Camilli T, Zhang F, Tanabe T, McCaffrey TA, Dannenberg AJ and Weksler BB. 2000. Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-?B. J. Biol. Chem., 275:4949-4956.
69. Subbaramaiah K, Michaluart P, Sporn MB and Dannenberg AJ. 2000. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res., 60:239-2404.   
70. Subbaramaiah K, Hart JC, Norton L and Dannenberg AJ. 2000. Microtubule interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 MAP kinase pathways. J. Biol. Chem., 275:14838-14845.
71. Nieto N, Greenwel P, Friedman SL, Zhang F, Dannenberg AJ and Cederbaum AI. 2000. Ethanol and arachidonic acid increase a2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1: Role of H2O2 and cyclooxygenase-2. J. Biol. Chem., 275:20136-20145.
72. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AT. 2000. COX-2 is expressed in human pulmonary, colonic and mammary tumors. Cancer, 89:2637-2645.
73. Weyant MJ, Carothers AM, Dannenberg AJ and Bertagnolli MM. 2001. ( )-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase (FAK) activation in the Min/ mouse. Cancer Res., 61:118-125.
74. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K and Dannenberg AJ. 2001. Cyclooxygenase-2 is overexpressed in human cervical cancer, Clin. Cancer Res., 7:429-434.
75. Subbaramaiah K, Bulic P, Lin Y, Dannenberg AJ and Pasco D. Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription, J. Biomol. Screen., in press.
76. Subbaramaiah K, Lin DT, Hart JC and Dannenberg AJ. PPAR? ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of AP-1 and CBP/p300, J. Biol. Chem., in press.
77. Khan KNM, Stanfield KM, Dannenberg AJ, Seshan SV, Baergen RN, Baron DA and Soslow RA. Cyclooxygenase-2 expression in the developing human kidney, Ped. Develop. Path., in press.
78. Mackrell PJ, Daly JM, Mestre JR, Stapleton PP, Howe LR, Subbaramaiah K and Dannenberg AJ. Elevated expression of cyclooxygenase-2 contributes to immune dysfunction in a murine model of trauma, submitted.
79. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ and Brown AMC. PEA3 is up-regulated in response to Wnt-1 and activates the expression of cyclooxygenase-2, submitted.
80. Howe LR, Subbaramaiah K, Brown AMC and Dannenberg AJ. Cyclooxygenase-2: A target for the prevention and treatment of breast cancer, submitted.
81. Yoshimatsu K, Altorki NK, Zhang F, Jakobsson P-J, Dannenberg AJ and Subbaramaiah K. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer, submitted.
82. Zhang F, Altorki NK, Wu Y-C, Soslow RA, Subbaramaiah K and Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats. Evidence for involvement of bile acids, submitted.
83. de Ledinghen V, Liu H, Zhang F, Lo CR, Subbaramaiah K, Dannenberg AJ and Czaja M. Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1 expressing hepatocytes, submitted.
84. Subbaramaiah K, Norton L, Gerald W, Koki AT and Dannenberg AJ. Increased expression of cyclooxygenase-2 in HER-2/neu-overexpressing breast cancer, in preparation.
85. Koki AT, Altorki NK, Masferrer JL, Zhang F, Subbaramaiah K, Kumar A, Yang EK, Soslow RA, Thaler HT, Raz A, Woerner BM, Zweifel BS, Wu Y-C and Dannenberg AJ. Cyclooxygenase-2 and cytosolic phospholipase A2 are overexpressed in human non-small cell lung cancer, in preparation.

Books and Journals:

1. Zakim D and Dannenberg AJ [eds]. 1991. Peptic Ulcer Disease and Other Acid-Related Disorders, Academic Research Associates, Armonk, NY.
2. Dannenberg AJ and Schantz SP [eds]. 1997. Perspectives in Cancer Prevention, Blackwell Science, Inc., Cambridge, MA.

Chapters and Reviews:

1. Fine SN, Dannenberg AJ and Zakim D. 1991. The impact of medical therapy on peptic ulcer disease. In: Peptic Ulcer Disease and Other Acid-Related Disorders (Zakim D & Dannenberg AJ, eds) Academic Research Associates, New York, p. 1-13.
2. Subbaramaiah K, Zakim D, Weksler BB and Dannenberg AJ. 1997. Inhibition of cyclooxygenase: a novel approach to cancer prevention. In: Perspectives in Cancer Prevention (Dannenberg AJ & Schantz SP, eds) Blackwell Science, Inc., Massachusetts, 216:201-210.
3. Subbaramaiah K, Michaluart P and Dannenberg AJ. 2001. Resveratrol, a novel inhibitor of cyclooxygenase-2 gene expression. In: Polyphenols and Health (Vercauteren J, ed), in press.
4. Subbaramaiah K and Dannenberg AJ. 2001. Resveratrol inhibits the expression of cyclooxygenase-2 in mammary epithelial cells. In: Nutrition and Cancer Prevention, in press.   
5. Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, Isakson P, Edwards D, Hardy M and Masferrer JL. 2001. Cyclooxygenase-2 in human pathological disease. In: Proceedings on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation, and Related Diseases, in press.
6. Dannenberg AJ, Subbaramaiah K and Gordon GB. 2001. Prevention of colorectal cancer. In: Principles & Practice of Gastrointestinal Oncology (Kelsen D, Levin B, Tepper J, Daly J, Kern S, eds.), Lippincott Williams & Wilkins, Pennsylvania, in press.
7. Dannenberg AJ and Nanjii AA. 2001. Cyclooxygenase-2: a potential target for the prevention and treatment of alcoholic liver disease. In: Steatohepatitis (NASH and ASH)-Falk Symposium 121, in press.    
8. Dannenberg AJ, Altorki NK and Subbaramaiah. 2001. Selective inhibitors of COX-2: New applications in oncology. In: ASCO educational book, in press.

Abstracts:

1. Dannenberg AJ, Perdue JF and Daughaday WH. 1982. Preferential binding of insulin-like growth factor II to Swarm rat chondrosarcoma membrane. The Endocrine Society Meeting.
2. Dannenberg A, Hochman Y and Zakim D. 1986. The effect of endotoxin on lipid-protein interactions. Hepatology 6(5): 1188.
3. Dannenberg A and Zakim D. 1989. Effects of a lipid-free diet on liver microsomal UDP-glucuronosyltransferase. Gastroenterology 96:589.   
4. Dannenberg AJ and Worman H. 1990. Developmental changes in the function of hepatic microsomal UDP-glucuronosyltransferase. Gastroenterology 98:580.
5. Tucker JK and Dannenberg AJ. 1990. Sex differences in UDP-glucuronosyltransferase activity. Gastroenterology 98:670.
6. Dannenberg AJ, Park S and Zakim D. 1990. Regulation of microsomal UDP-glucuronosyltransferase by protein-protein interactions. Hepatology 12: 446.
7. Dannenberg AJ, Radominska A, Scarlata S and Zakim D. 1991. Effect of high pressure treatment on the properties of human liver microsomal UDP-glucuronosyltransferase. FASEB J: 2770.
8. Zakim D, Kavecansky J and Dannenberg AJ. 1991. Regulation of multiple, active states of UDP-glucuronosyltransferase by the membrane. In: Workshop on Glucuronidation, Abstr. No. 19, Noordwijkerhout, The Netherlands.
9. Dannenberg AJ and Salbe AD. 1991. Regulation of the activity of liver microsomal UDP-glucuronosyltransferase (GT) by inducers in the diet. Hepatology 14(4):228A.    
10. Dannenberg AJ and Zakim D. 1991. Regulation of the amount and functional state of UDP-glucuronosyltransferase (GT) by dietary lipid. Hepatology 14(4):144A.
11. Yang EK and Dannenberg AJ. 1992. Regulation of UDP-glucuronosyltransferase (GT) by dietary lipid. FASEB J:5912.
12. Dannenberg AJ and Yang EK. 1992. Hepatic levels of UDP-glucuronosyltransferase (GT) activity are determined by dietary lipids. Gastroenterology 102(4):797.
13. Dannenberg AJ and Felig D. 1992. Induction of liver and skin UDP-glucuronosyltransferase (GT) by coal tar and its constituents. Gastroenterology 102(4):797.
14. Nanji AA, Zhao S, Sadrzadeh SHH, Dannenberg A and Waxman DJ. 1992. Microsomal fatty acid changes in experimental alcoholic liver injury: relationship to levels of cytochrome P450 2E1 and microsomal conjugated dienes. Gastroenterology 102(4):859.
15. Dannenberg AJ and Yang EK. 1992. Regulation of hepatic phase II enzymes by dietary lipids. In: AASLD Single-Topic Conference (Differentiation of Hepatocytes), Abstr. No. 10, Mackinac Island, Michigan.
16. Dannenberg AJ and Yang EK. 1992. Hepatic levels of phase II enzymes are regulated by dietary lipids. In: Proceedings of 9th International Symposium on Microsomes and Drug Oxidations, Abstr. No. 82, Jerusalem, Israel.
17. Dannenberg AJ and Yang EK. 1992. Regulation of glutathione S-transferase activity in liver and small intestine by dietary lipids. In: Functions of Glutathione in Gut and Liver, Abstr. No. 20, Basel, Switzerland.
18. Nanji AA, Lamb RG, Sadrzadeh SMH, Zhao S, Dannenberg AJ and Waxman DJ. 1992. Liver microsomal phospholipases A and C in experimental alcoholic liver injury: relationship to arachidonic acid and cytochrome P450 2E1. Hepatology 16(4):111A.
19. Dannenberg AJ, Aharon D and Yang EK. 1992. Effect of dietary lipid saturation on hepatic phase II enzymes. Hepatology 16(4):112A.
20. Dannenberg AJ and Yang EK. 1992. Hepatic biotransformation is regulated by dietary lipids. Hepatology 16(4):230A.
21. Dannenberg AJ and Yang EK. 1993. Dietary lipids regulate the activities of phase II enzymes in the small intestine. Gastroenterology 104(4):616.
22. Dannenberg AJ and Yang EK. 1993. Dietary lipids coinduce multiple xenobiotic metabolizing enzymes in rat liver. In: Fatty Acids and Lipids From Cell Biology To Human Disease, Abstr. No. 84, Lugano, Switzerland.
23. Dannenberg AJ, Yang EK and Kashfi K. 1993. Dietary regulation of UDP-glucuronosyltransferase. In: 7th International Workshop on Glucuronidation and the UDP-glucuronosyltransferases, page 19, Pitlochry, Scotland.
24. Dannenberg AJ, Yang EK and Waxman DJ. 1993. Dietary lipids coordinately regulate the expression of genes coding for xenobiotic metabolizing enzymes. Hepatology 18(4):126A.
25. Yang EK, Kashfi K, Roy Chowdhury N, Roy Chowdhury J and Dannenberg AJ. 1993. Effect of dietary composition on bilirubin-UDP-glucuronosyltransferase. Hepatology 18(4):127A.
26. Kashfi K, Rimarachin JA, Weksler BB and Dannenberg AJ. 1993. Differential regulation of glutathione S-transferase in rat aorta versus liver. Clinical Research 41(3):595A.
27. Kashfi K, Yang EK, Roy Chowdhury N, Roy Chowdhury J and Dannenberg AJ. 1994. Regulation of UDP-glucuronosyltransferase gene expression by antioxidants. Gastroenterology 106(4):916.
28. Kashfi K, Rimarachin JA, Weksler BB and Dannenberg AJ. 1994. Effect of a fat free diet on glutathione S-transferase (GST) in the rat aorta. FASEB J: 1207.
29. Kashfi K and Dannenberg AJ. 1994. Omeprazole coinduces multiple xenobiotic metabolizing enzymes in rat liver. Hepatology 20(4):187A.
30. Nanji AA, Sadrzadeh SMH, Fogt F, Meydani M and Dannenberg AJ. 1994. Treatment of established alcoholic liver disease in the rat using a diet rich in saturated fatty acids. Hepatology 20(4):315A.
31. Ramonetti J, Kashfi K, Yang EK, Wong GY and Dannenberg AJ. 1994. Effect of dietary lipid saturation on xenobiotic metabolizing enzymes in the liver. Hepatology 20(4):389A.
32. Kashfi K, Zhang Y, Yang EK, Talalay P and Dannenberg AJ. 1995.   Anticarcinogenic organic isothiocyanates induce UDP-glucuronosyltransferase. FASEB J: A868.
33. Kashfi K, McDougall CJ and Dannenberg AJ. 1995. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human small intestine. Gastroenterology 108(4):A129.
34. Kashfi K, Yang EK, Zhang Y, Talalay P and Dannenberg AJ. 1995. Anticarcinogenic organic isothiocyanates coordinately induce multiple xenobiotic metabolizing enzymes in liver and small intestine. Gastroenterology 108(4):A488.
35. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F and Dannenberg AJ. 1995. Medium chain triglycerides and vitamin E are effective in treating alcoholic liver injury. Gastroenterology 108(4):A1131.
36. Nanji AA, Rahemtulla A, Daly T, Khwaja S, Griniuviene B and Dannenberg AJ. 1995. Treatment with dietary saturated fatty acids reduces endotoxemia, TNFa mRNA and collagen in experimental alcoholic liver disease. Hepatology 22(4):476.
37. Nanji AA, Miao L, Khwaja S, Zhao S, Fogt F, Tahan SR and Dannenberg AJ. 1995. Increased in vivo expression of inducible cyclooxygenase-2 (Cox-2) in experimental alcoholic liver disease. Hepatology 22(4):543.
38. Yang EK, Leonard J, Sepkovic D, Bradlow HL, Ramonetti J and Dannenberg AJ. 1995. Effect of butylated hydroxytoluence (BHT) on UDP-glucuronosyltransferase (UGT) gene expression in rat liver. Hepatology 22(4):781.
39. Subbaramaiah K, Ramonetti JT, Telang N, Kelley DJ, Mestre JR, Sacks PG, Schantz SP, Leonard J and Dannenberg AJ. 1996. Retinoids inhibit cyclooxygenase-2. In: New targets in inflammation: inhibitors of Cox-2 or adhesion molecules. Abstract No. 20, New Orleans, LA.
40. Boolbol SK, Dannenberg AJ, Chadburn AS, Martucci C, Guo XJ, Ramonetti JT, Newmark HL, Lipkin ML, DeCosse JJ and Bertagnolli MM. 1996. Sulindac prevents tumors in a murine model of familial adenomatous polyposis, Proc. Am. Assn. Cancer Res., 37:1863.
41. Kelley DJ, Sacks PG, Ramonetti JT, Schantz SP and Dannenberg AJ. 1996. Curcumin inhibits prostaglandin synthesis and cyclooxygenase-2 expression in oral epithelial cells, Proc. Am. Assn. Cancer Res., 37:4103.
42. Kelley DJ, Sacks PG, Ramonetti JT, Schantz SP and Dannenberg AJ. 1996. Benzo[a]pyrene up-regulates cyclooxygenase-2 and prostaglandin synthesis in human oral epithelial cells, Proc. Am. Assn. Cancer Res., 37:909.
43. Subbaramaiah K, Ramonetti JT, Telang N and Dannenberg AJ. 1996. Retinoids inhibit cyclooxygenase-2 gene expression and prostaglandin synthesis in mammary epithelial cells, Proc. Am. Assn. Cancer Res., 37:1856.
44. Dannenberg AJ, Ramonetti JT, Subbaramaiah K, Araki R, Weksler BB and Telang N. 1996. Cyclooxygenase-2 (Cox-2) is up-regulated in transformed mammary epithelial cells, Proc. Am. Assn. Cancer Res., 37:1006.
45. Nanji AA, Rahemtulla A, Miao L, Yang EK, Zhao S and Dannenberg AJ. 1996. Treatment with dietary saturated fatty acids improves liver pathology despite continued ethanol administration. Gastroenterology, 110(4):A1275.
46. Nanji AA, Miao L, Thomas P, Zhao S, Rahemtulla A, Tahan SR, Peters D and Dannenberg AJ. 1996. Increased cyclooxygenase-2 (Cox-2) expression in Kupffer cells correlates with pathologic injury in experimental alcoholic liver disease. Gastroenterology, 110(4):A1274.
47. Nanji AA, Dannenberg AJ and Bass NM. 1996. Dietary fat composition influences cell injury in experimental alcoholic liver disease and has divergent effects on the expression of liver fatty acid binding protein and enzymes of extramitochondrial fatty acid oxidation. Gastroenterology, 110(4):A1274.
48. Roy Chowdhury J, Yang EK, Seppen J, Tada K and Dannenberg AJ and Roy Chowdhury N. 1996. Human and rat bilirubin-UDP-glucuronosyltransferase-1 catalyze the glucuronidation of carcinogenic metabolites of benzo(a)pyrene. Gastroenterology, 110(4):A1171.
49. Nanji AA and Dannenberg AJ. 1996. Ethanol alters the fatty acid composition of hepatocytes, kupffer and endothelial cells in rat liver. Alcoholism: Clin. Exp. Res.